The goal is not only to improve efficacy, but to differentiate products in a crowded and high-stakes market
Within approved clinical trial settings, the preparation of injectable investigational medicinal products (IMPs) must comply with Good Clinical Practice (GCP), the trial protocol, and local aseptic compounding policies
Trends Neurosci 34:7687 Bradaia A, Schlichter R, Trouslard J (2004) Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord
Compounded versions have not been evaluated by the FDA and may pose safety risks
As science evolves, the future of anti-aging peptides offers great potential to change how we address aging at its core
Structural rejuvenation is integrated within the brightening architecture to ensure that clarity is supported by firmness rather than superficial lightening